You just read:

GHIT Fund Invests in Late-stage Trial for Child-friendly "Snail Fever" Medicines--One of the Most Debilitating and Widespread Parasitic Diseases in Africa

News provided by

Global Health Innovative Technology Fund (GHIT Fund)

Mar 29, 2017, 20:01 ET